NOTES
2. Assets held for sale and discontinued operations
On 6 August 2026, Medicover entered into a share purchase agreement to dispose all of its hospital operations in India. The regulatory approval required for the disposal was obtained in October 2026. The parties are in the process of completing the remaining pre-closing actions. The transaction is expected to be completed by the end of November 2026.
In this Q3 2026 interim report, the disposal group has been classified as held for sale and as discontinued operation in accordance with IFRS 5. The related assets and liabilities have therefore been presented separately as assets held for sale and as liabilities directly associated with assets held for sale. The financial performance of the Indian hospital operations is presented as discontinued operations for all periods presented in this interim report. The amounts are presented after elimination of intra-group transactions and balances.
Financial performance of discontinued operations
| EUR million | Q3 2026 | Q3 2025 | 9M 2026 | 9M 2025 | LTM | FY 2025 |
|---|---|---|---|---|---|---|
| Revenue | 67.4 | 52.9 | 181.1 | 148.4 | 233.4 | 200.7 |
| Expenses | -67.7 | -53.8 | -186.7 | -156.0 | -241.7 | -211.0 |
| Loss before income tax | -0.3 | -0.9 | -5.6 | -7.6 | -8.3 | -10.3 |
| Income tax | 0.7 | 0.3 | 3.4 | 3.9 | 4.3 | 4.8 |
| Profit/(loss) from discontinued operations | 0.4 | -0.6 | -2.2 | -3.7 | -4.0 | -5.5 |
Assets and liabilities relating to the disposal group
| EUR million | 30 Sep 2026 |
|---|---|
| Goodwill | 55.9 |
| Property, plant and equipment | 75.2 |
| Right-of-use assets | 124.3 |
| Deferred tax assets | 27.3 |
| Trade and other receivables | 85.0 |
| Cash and cash equivalents | 1.1 |
| Other assets | 18.8 |
| Total assets classified as held for sale | 387.6 |
| Loans payable | 29.8 |
| Lease liabilities | 143.0 |
| Trade and other payables | 37.7 |
| Other liabilities | 3.8 |
| Total liabilities associated with assets classified as held for sale | 214.3 |
The cumulative foreign exchange loss recognised in other comprehensive income in relation to the disposal group as at 30 September 2026 was EUR 28.7 million.
The proceeds of disposal will substantially exceed the carrying value of the related net assets and accordingly no impairment loss has been recognised in connection with the classification of the operations as held for sale.